Session

PP 09 COVID-19 (Posters)

MICROBIOME MODIFICATION AND IMPROVEMENT OF SIGNS AND SYMPTOMS OF COVID-19: ILEOCOLONIC-RELEASE NICOTINAMIDE IN A PROSPECTIVE, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL
MICROBIOME MODIFICATION AND IMPROVEMENT OF SIGNS AND SYMPTOMS OF COVID-19: ILEOCOLONIC-RELEASE NICOTINAMIDE IN A PROSPECTIVE, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL

PP 09 COVID-19 (Posters)  et al.

GUT MICROBIOTA IS ASSOCIATED WITH PERSISTENCE OF LONGER-TERM VACCINE IMMUNOGENICITY AFTER TWO DOSES OF BNT162B2
GUT MICROBIOTA IS ASSOCIATED WITH PERSISTENCE OF LONGER-TERM VACCINE IMMUNOGENICITY AFTER TWO DOSES OF BNT162B2

PP 09 COVID-19 (Posters)  et al.

TREATMENT MODALITIES FOR POST-COVID-19 ESOPHAGO-GASTRIC JUNCTION DISORDERS
TREATMENT MODALITIES FOR POST-COVID-19 ESOPHAGO-GASTRIC JUNCTION DISORDERS

PP 09 COVID-19 (Posters)  et al.

PERI-OPERATIVE COVID-19 INFECTION AND SUBSEQUENT MORTALITY DURING THE COVID-19 PANDEMIC
PERI-OPERATIVE COVID-19 INFECTION AND SUBSEQUENT MORTALITY DURING THE COVID-19 PANDEMIC

PP 09 COVID-19 (Posters)  et al.

SEVERE COVID-19 INFECTION CAUSES LONG-TERM ALTERATIONS OF THE GUT-LIVER AXIS
SEVERE COVID-19 INFECTION CAUSES LONG-TERM ALTERATIONS OF THE GUT-LIVER AXIS

PP 09 COVID-19 (Posters)  et al.

CHANGES IN THE MICROBIOME AND THE EFFECTS OF A SYNBIOTIC INTERVENTION IN HOME-QUARANTINED PATIENTS WITH MILD SARS-COV-2 INFECTION: A RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED, TELEMEDICINE STUDY (SYNCOV STUDY)
CHANGES IN THE MICROBIOME AND THE EFFECTS OF A SYNBIOTIC INTERVENTION IN HOME-QUARANTINED PATIENTS WITH MILD SARS-COV-2 INFECTION: A RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED, TELEMEDICINE STUDY (SYNCOV STUDY)

PP 09 COVID-19 (Posters)  et al.

LIVER AND COVID-19 - NEW INSIGHTS AND EARLY PROGNOSTIC MARKERS
LIVER AND COVID-19 - NEW INSIGHTS AND EARLY PROGNOSTIC MARKERS

PP 09 COVID-19 (Posters)  et al.

THE EFFECT OF HEPATOSTEATOSIS AND LIVER FIBROSIS ON THE PROGNOSIS OF HOSPITALIZED COVID-19 PATIENTS
THE EFFECT OF HEPATOSTEATOSIS AND LIVER FIBROSIS ON THE PROGNOSIS OF HOSPITALIZED COVID-19 PATIENTS

PP 09 COVID-19 (Posters)  et al.

SEVERE COVID-19 INFECTION CAUSES LONG-TERM ALTERATIONS OF THE GUT-LIVER AXIS
SEVERE COVID-19 INFECTION CAUSES LONG-TERM ALTERATIONS OF THE GUT-LIVER AXIS

CHANGES IN THE MICROBIOME AND THE EFFECTS OF A SYNBIOTIC INTERVENTION IN HOME-QUARANTINED PATIENTS WITH MILD SARS-COV-2 INFECTION: A RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED, TELEMEDICINE STUDY (SYNCOV STUDY)
CHANGES IN THE MICROBIOME AND THE EFFECTS OF A SYNBIOTIC INTERVENTION IN HOME-QUARANTINED PATIENTS WITH MILD SARS-COV-2 INFECTION: A RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED, TELEMEDICINE STUDY (SYNCOV STUDY)

LIVER AND COVID-19 - NEW INSIGHTS AND EARLY PROGNOSTIC MARKERS
LIVER AND COVID-19 - NEW INSIGHTS AND EARLY PROGNOSTIC MARKERS

THE EFFECT OF HEPATOSTEATOSIS AND LIVER FIBROSIS ON THE PROGNOSIS OF HOSPITALIZED COVID-19 PATIENTS
THE EFFECT OF HEPATOSTEATOSIS AND LIVER FIBROSIS ON THE PROGNOSIS OF HOSPITALIZED COVID-19 PATIENTS

GUT MICROBIOTA IS ASSOCIATED WITH PERSISTENCE OF LONGER-TERM VACCINE IMMUNOGENICITY AFTER TWO DOSES OF BNT162B2
GUT MICROBIOTA IS ASSOCIATED WITH PERSISTENCE OF LONGER-TERM VACCINE IMMUNOGENICITY AFTER TWO DOSES OF BNT162B2

TREATMENT MODALITIES FOR POST-COVID-19 ESOPHAGO-GASTRIC JUNCTION DISORDERS
TREATMENT MODALITIES FOR POST-COVID-19 ESOPHAGO-GASTRIC JUNCTION DISORDERS

PERI-OPERATIVE COVID-19 INFECTION AND SUBSEQUENT MORTALITY DURING THE COVID-19 PANDEMIC
PERI-OPERATIVE COVID-19 INFECTION AND SUBSEQUENT MORTALITY DURING THE COVID-19 PANDEMIC

MICROBIOME MODIFICATION AND IMPROVEMENT OF SIGNS AND SYMPTOMS OF COVID-19: ILEOCOLONIC-RELEASE NICOTINAMIDE IN A PROSPECTIVE, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL
MICROBIOME MODIFICATION AND IMPROVEMENT OF SIGNS AND SYMPTOMS OF COVID-19: ILEOCOLONIC-RELEASE NICOTINAMIDE IN A PROSPECTIVE, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL

Item 1 - 16 / 16
1